Mironid appoints Dr Catherine Kelleher as Chief Medical Officer Mironid appoints Dr Catherine Kelleher as Chief Medical Officer October 24 2023, Glasgow, Scotland – Mironid, a biopharmaceutical company developing small molecule therapeutics for the treatment of...

Mironid extends Series A round raising £35 million to date for development of first-in-class small molecules to treat life-threatening hereditary kidney disease Roche Venture Fund joins existing major investors Epidarex Capital, Sofinnova Partners and BioGeneration Ventures September 13, 2023: Glasgow, Scotland – Mironid, a biopharmaceutical company...